Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
Hypomyelinating leukodystrophies (HLDs) represent a group of congenital rare diseases for which the responsible genes have been identified in recent studies. In this review, we briefly describe the genetic/molecular mechanisms underlying the pathogenesis of HLD and the normal cellular functions of t...
Main Authors: | Tomohiro Torii, Junji Yamauchi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.mdpi.com/2035-8377/15/3/72 |
Similar Items
-
Hypomyelinating leukodystrophy and movement disorders
by: Jacky Ganguly, et al.
Published: (2023-01-01) -
Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen
by: Sui Sawaguchi, et al.
Published: (2021-12-01) -
Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen
by: Sui Sawaguchi, et al.
Published: (2022-02-01) -
Novel Gene Mutation Variant in Hypomyelinating Leukodystrophy-8: A Case Report
by: Shalesh Rohatgi, et al.
Published: (2024-11-01) -
The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy
by: Andreas J. Hülsmeier, et al.
Published: (2023-12-01)